Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)
Status:
Completed
Trial end date:
2016-10-20
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to assess the effect of a single dose of gefapixant
100 mg on cough reflex sensitivity to various challenge agents (capsaicin, citric acid,
adenosine triphosphate [ATP], and distilled water) in healthy and chronic cough participants.